Beta Bionics Ownership | Who Owns Beta Bionics?


OverviewForecastRevenueFinancialsChartTranscripts

Beta Bionics Ownership Summary


Beta Bionics is owned by 26.51% institutional investors, 0.63% insiders, and 72.86% retail investors. Eventide asset management is the largest institutional shareholder, holding 11.42% of BBNX shares.

BBNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeta Bionics26.51%0.63%72.86%
SectorHealthcare Stocks 232.64%10.66%-143.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eventide asset management4.96M11.42%$98.50M
Farallon capital management4.31M9.94%$85.72M
Wellington management group llp3.90M8.99%$77.52M
Sands capital ventures3.57M8.23%$70.94M
Morgan stanley3.46M7.93%$105.41M
Rtw investments, lp3.30M7.60%$65.55M
Blackrock funding, inc. /de2.91M6.68%$88.79M
Soleus capital management2.53M5.81%$77.23M
Vanguard group2.22M5.08%$67.59M
Omega fund management1.92M4.43%$38.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pura vida investments281.25K34.05%$5.59M
Omega fund management1.92M17.16%$38.15M
Sands capital ventures3.57M15.54%$70.94M
Soleus capital management2.53M2.85%$77.23M
Eventide asset management4.96M1.62%$98.50M
Kent lake pr125.00K1.25%$2.48M
Rtw investments, lp3.30M0.81%$65.55M
Essex investment management222.62K0.68%$4.42M
Values first advisors35.19K0.56%$1.07M
Vestal point capital, lp600.00K0.54%$11.92M

Top Buyers

HolderShares% AssetsChange
State street826.30K0.00%596.31K
Walleye capital591.19K0.04%373.00K
Norges bank339.30K0.00%339.30K
Pura vida investments281.25K34.05%278.75K
Charles schwab investment management330.69K0.00%228.47K

Top Sellers

HolderShares% AssetsChange
Soleus capital management2.53M2.85%-1.34M
Perceptive advisors277.94K0.16%-1.32M
Divisadero street capital management, lp---948.97K
Arrowmark colorado---925.36K
Holocene advisors, lp---770.85K

New Positions

HolderShares% AssetsChangeValue
Norges bank339.30K0.00%339.30K$10.34M
Essex investment management222.62K0.68%222.62K$4.42M
Kent lake pr125.00K1.25%125.00K$2.48M
Granahan investment management85.74K0.07%85.74K$1.70M
Meridiem capital partners lp73.39K0.09%73.39K$1.46M

Sold Out

HolderChange
Fortitude family office-35.00
Clearstead advisors-90.00
Private trust co na-209.00
Quarry lp-667.00
Bank of new hampshire-680.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202563-50.78%11,567,343-76.07%260.22%45-48.28%8-61.90%
Sep 30, 202551-55.65%7,817,160-82.57%180.17%31-51.56%5-82.14%
Jun 30, 202511515.00%44,849,3148.81%1030.57%66-34.00%28-
Mar 31, 2025102-42,347,979-137-102---

Recent Insider Transactions


DateNameRoleActivityValue
Dec 02, 2025Hopman Mark Chief Commercial OfficerSell$25.11K
Dec 04, 2025Hopman Mark Chief Commercial OfficerSell$63.19K
Dec 02, 2025Russell Steven Jon Chief Medical OfficerSell$30.07K
Mar 04, 2026Hopman Mark Chief Commercial OfficerSell$4.08K
Mar 02, 2026Hopman Mark Chief Commercial OfficerSell$10.31K

Insider Transactions Trends


DateBuySell
2026 Q1-10
2025 Q4-15
2025 Q3-12
2025 Q2-15
2025 Q1--

BBNX Ownership FAQ


Who owns the most shares of Beta Bionics?

Beta Bionics’s largest shareholders are Eventide asset management (4.96M shares, 11.42%), Farallon capital management (4.31M shares, 9.94%), and Wellington management group llp (3.9M shares, 8.99%). Together, they hold 30.36% of Beta Bionics’s total shares outstanding.

Does Blackrock own Beta Bionics?

BlackRock is not among the top 10 institutional shareholders of Beta Bionics.

Who is Beta Bionics’s biggest shareholder by percentage of total assets invested?

Pura vida investments is Beta Bionics’s biggest shareholder by percentage of total assets invested, with 34.05% of its assets in 281.25K Beta Bionics shares, valued at 5.59M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools